You are here

Regeneron Covid-19 treatment enters final stage trials

[WASHINGTON] The pharmaceutical firm Regeneron on Monday announced it was entering the late stages of its human clinical trials investigating a drug to both treat and prevent Covid-19.

The drug, called REGN-COV2, is a combination of two antibodies that block the coronavirus' "spike...

BT is now on Telegram!

For daily updates on weekdays and specially selected content for the weekend. Subscribe to t.me/BizTimes